- Home
- TWIN vs VXRT Comparison
TWIN vs VXRT Comparison
Compare TWIN & VXRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TWIN
- VXRT
- Stock Information
- Founded
- TWIN 1918
- VXRT N/A
- Country
- TWIN United States
- VXRT United States
- Employees
- TWIN N/A
- VXRT N/A
- Industry
- TWIN Industrial Machinery/Components
- VXRT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TWIN Industrials
- VXRT Health Care
- Exchange
- TWIN Nasdaq
- VXRT Nasdaq
- Market Cap
- TWIN 123.7M
- VXRT 119.0M
- IPO Year
- TWIN N/A
- VXRT N/A
- Fundamental
- Price
- TWIN $7.68
- VXRT $0.40
- Analyst Decision
- TWIN
- VXRT Strong Buy
- Analyst Count
- TWIN 0
- VXRT 2
- Target Price
- TWIN N/A
- VXRT $3.00
- AVG Volume (30 Days)
- TWIN 42.1K
- VXRT 1.7M
- Earning Date
- TWIN 04-29-2025
- VXRT 03-20-2025
- Dividend Yield
- TWIN 2.10%
- VXRT N/A
- EPS Growth
- TWIN N/A
- VXRT N/A
- EPS
- TWIN 0.68
- VXRT N/A
- Revenue
- TWIN $321,398,000.00
- VXRT $28,700,000.00
- Revenue This Year
- TWIN N/A
- VXRT N/A
- Revenue Next Year
- TWIN N/A
- VXRT $48.02
- P/E Ratio
- TWIN $11.77
- VXRT N/A
- Revenue Growth
- TWIN 9.23
- VXRT 288.94
- 52 Week Low
- TWIN $7.35
- VXRT $0.39
- 52 Week High
- TWIN $18.00
- VXRT $1.34
- Technical
- Relative Strength Index (RSI)
- TWIN 35.25
- VXRT 30.14
- Support Level
- TWIN $8.00
- VXRT $0.49
- Resistance Level
- TWIN $8.84
- VXRT $0.60
- Average True Range (ATR)
- TWIN 0.41
- VXRT 0.05
- MACD
- TWIN 0.09
- VXRT -0.01
- Stochastic Oscillator
- TWIN 28.19
- VXRT 9.77
About TWIN Twin Disc Incorporated
Twin Disc Inc is a United States-based firm engaged in the manufacture and sale of marine and heavy-duty off-highway power transmission equipment. The company operates its business through two reportable segments: Manufacturing and Distribution. Its product portfolio includes marine transmissions, surface drives, propellers, and boat management systems as well as power-shift transmissions, hydraulic torque converters, power take-offs, industrial clutches, and control systems.
About VXRT Vaxart Inc
Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States.